ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,396Medicare Part D Prescriptions Filled, Including Refills

Rank: 220 out of 2802

$286K Total Retail Price of All Prescriptions

Rank: 1237 out of 2802

1,652 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New York
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 1,652 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$27 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

6 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 536 458 208 1 3
SIMVASTATIN 440 408 161 2 1
LISINOPRIL 360 304 128 3 5
ATORVASTATIN CALCIUM 342 302 111 4 6
TEMAZEPAM 281 270 106 B 5 251
VITAMIN D2 269 222 166 6 145
ALENDRONATE SODIUM 222 204 88 7 24
AMLODIPINE BESYLATE 216 195 91 8 4
METFORMIN HCL 213 168 89 9 7
LOSARTAN POTASSIUM 197 162 67 10 14
SYNTHROID 191 191 72 11 40
RANITIDINE HCL 190 185* 71 12 38
LEVOTHYROXINE SODIUM 168 132 51 13 2
FOLIC ACID 167 149 71 14 262
METOPROLOL SUCCINATE 166 153 65 15 11
ATENOLOL 165 129 60 16 13
HYDROCHLOROTHIAZIDE 164 144 67 17 10
GABAPENTIN 162 125 73 18 19
RENAL CAPS 154 149* 61 19 423
FLUTICASONE PROPIONATE 146 117 82 20 36
ALPRAZOLAM 142 137* 70 B 21 31
PANTOPRAZOLE SODIUM 140 122 58 22 29
IBUPROFEN 135 112 99 23 64
METOPROLOL TARTRATE 122 103 53 24 9
CLOPIDOGREL 120 85 43 25 16
FUROSEMIDE 108 97 53 26 8
TRAMADOL HCL-ACETAMINOPHEN 107 90 77 27 242
ENALAPRIL MALEATE 99 94* 40 28 26
LOSARTAN-HYDROCHLOROTHIAZIDE 97 92* 30 29 44
TAMSULOSIN HCL 95 90* 42 30 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 75 27 31 34
VOLTAREN 85 80* 53 32 72
GLIPIZIDE 78 73* 30 33 69
CITALOPRAM HBR 78 73* 37 33 25
DONEPEZIL HCL 74 74 32 35 33
CARVEDILOL 74 55 31 35 27
DICLOFENAC SODIUM 73 59 55 37 144
WARFARIN SODIUM 73 68* 34 37 12
VIAGRA 73 68* 31 37 488
CRESTOR 66 50 21 40 18
PRAVASTATIN SODIUM 66 61* 23 40 17
PROCTOZONE-HC 62 57* 39 42 245
LORAZEPAM 61 56* 23 B 43 67
LOVASTATIN 60 55* 27 44 48
LANSOPRAZOLE 59 54* 18 45 138
VENTOLIN HFA 59 39 22 45 73
MELOXICAM 58 53* 36 47 47
ADVAIR DISKUS 56 51* 24 48 35
GEMFIBROZIL 54 37 28 49 124
CIALIS 53 48* 21 50 525
CLOTRIMAZOLE-BETAMETHASONE 50 45* 30 51 135
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.